Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
Holst
J J
JJ
Department of Medical Physiology, University of Copenhagen, The Panum Institute, Blegdamsvej 3, 2200 Copenhagen N, Denmark. holst@mfi.ku.dk
Deacon
C F
CF
D000243:Adenosine Deaminase / Q000378:metabolism; D058892:Adenosine Deaminase Inhibitors; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005746:Gastric Emptying / Q000187:drug effects; D005934:Glucagon / Q000378:metabolism / Q000502:physiology*; D052216:Glucagon-Like Peptide 1; D006023:Glycoproteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D008954:Models, Biological; D009325:Nausea / Q000139:chemically induced; D010446:Peptide Fragments / Q000378:metabolism / Q000502:physiology*; D011498:Protein Precursors / Q000378:metabolism / Q000502:physiology*; D014839:Vomiting / Q000139:chemically induced
D058892:Adenosine Deaminase Inhibitors; D001786:Blood Glucose; D004791:Enzyme Inhibitors; D006023:Glycoproteins; D010446:Peptide Fragments; D011498:Protein Precursors; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4; D000243:Adenosine Deaminase